Reflect ScientificRSCF Net Margin % is 10.25% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Reflect Scientific ranks better than 58.63% on this metric.
The historical rank and industry rank for Reflect Scientific's Net Margin % or its related term are showing as below:
RSCF'
s Net Margin % Range Over the Past 10 Years
Min: -55.04 Med: -14.15 Max: 80.62
Current: 5.15
RSCF's Net Margin % is ranked better than 58.63% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs RSCF: 5.15
Reflect Scientific (OTCPK:RSCF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Reflect Scientific Net Margin % Related Terms
Reflect Scientific Net Margin % Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Net Margin % distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reflect Scientific (RSCF) has a Net Margin % of 10.25% as of Sep. 2025. Net margin is the ratio of total net income to net sales. View historical data on Reflect Scientific and its competitors. According to the industry distribution chart, Reflect Scientific ranks #338 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 41.4%.
Is Reflect Scientific's Net Margin % too high?
Reflect Scientific's current Net Margin % is 10.25%. The Medical Devices & Instruments industry median Net Margin % is 2.07. Reflect Scientific's value of 10.25% is 395.2% above this industry median. Based on the distribution chart, Reflect Scientific ranks #338 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Reflect Scientific's Net Margin % compare to GCTK and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #338 out of 817 companies for Net Margin %. This puts Reflect Scientific in the upper half of its industry. The industry median Net Margin % is 2.07. Reflect Scientific's value of 10.25% is 395.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Net Margin % of 10.25% is 395.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Net Margin % is 10.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Net Margin % of 10.25%. The current Net Margin % is 10.25% and 395.2% above the Medical Devices & Instruments industry median of 2.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Net Margin % is 10.25% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 